Company News
Lupin Receives US FDA Approval for Glycerol Phenylbutyrate
Lupin Limited receives US FDA approval for its Abbreviated New Drug Application for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL.
The approved product is bioequivalent to Ravicti® Oral Liquid
